These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 21295330)

  • 1. High-dose cyclophosphamide without stem cell rescue for the treatment of refractory Behcet's disease.
    Henderson CF; Brodsky RA; Jones RJ; Levine SM
    Semin Arthritis Rheum; 2011 Oct; 41(2):301-4. PubMed ID: 21295330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-dose intra-venous cyclophosphamide therapy in a patient with neurological complications of Behçet's disease.
    Melillo N; Sangle S; Stanford MR; Andrews TC; D'Cruz DP
    Clin Rheumatol; 2007 Aug; 26(8):1365-7. PubMed ID: 17063282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of vascular Behçet's disease.
    Alibaz-Oner F; Direskeneli H
    Int J Rheum Dis; 2019 Jan; 22 Suppl 1():105-108. PubMed ID: 29665281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of pulse cyclophosphamide and azathioprine in ocular manifestations of Behcet's disease: longitudinal study of up to 10 years.
    Davatchi F; Sadeghi Abdollahi B; Shams H; Shahram F; Nadji A; Chams-Davatchi C; Faezi T; Akhlaghi M; Ghodsi Z; Ashofteh F; Mohtasham N
    Int J Rheum Dis; 2014 May; 17(4):444-52. PubMed ID: 24314325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment of recurrent intracardiac thrombus in Behçet's disease with immunosuppressive therapy.
    Kaneko Y; Tanaka K; Yoshizawa A; Yasuoka H; Suwa A; Satoh T; Iwanaga S; Ogawa S; Ikeda Y; Hirakata M
    Clin Exp Rheumatol; 2005; 23(6):885-7. PubMed ID: 16396710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of anti-TNF alpha in severe and/or refractory Behçet's disease: Multicenter study of 124 patients.
    Vallet H; Riviere S; Sanna A; Deroux A; Moulis G; Addimanda O; Salvarani C; Lambert M; Bielefeld P; Seve P; Sibilia J; Pasquali J; Fraison J; Marie I; Perard L; Bouillet L; Cohen F; Sene D; Schoindre Y; Lidove O; Le Hoang P; Hachulla E; Fain O; Mariette X; Papo T; Wechsler B; Bodaghi B; Rigon MR; Cacoub P; Saadoun D;
    J Autoimmun; 2015 Aug; 62():67-74. PubMed ID: 26162757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical manifestations and anti-TNF alpha therapy of juvenile Behçet's disease in Taiwan.
    Hu YC; Yang YH; Lin YT; Wang LC; Yu HH; Lee JH; Chiang BL
    BMC Pediatr; 2019 Jul; 19(1):232. PubMed ID: 31296171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Azathioprine and low dose pulse cyclophosphamide in severe ocular lesions of Behçet's disease. A preliminary report.
    Shahram F; Davatchi F; Chams H; Nadji A; Jamshidi A; Akbarian M; Gharibdoost F
    Adv Exp Med Biol; 2003; 528():571-3. PubMed ID: 12918767
    [No Abstract]   [Full Text] [Related]  

  • 9. Update on the treatment of Behçet's syndrome.
    Esatoglu SN; Hatemi G
    Intern Emerg Med; 2019 Aug; 14(5):661-675. PubMed ID: 30684097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pentoxifylline for the treatment of anterior uveitis in Behcet's disease: possible alternative for TNF blockers.
    Appenzeller S; Hazel E
    Rheumatol Int; 2011 Nov; 31(11):1511-3. PubMed ID: 20013266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative immunosuppressive therapy reduces paravalvular leakage after aortic valve surgery in patients with aortic regurgitation attributable to Behçet's disease.
    Guo X; Tian Z; Liu Y; Li M; Zeng X; Fang Q
    Clin Exp Rheumatol; 2016; 34(6 Suppl 102):S26-S33. PubMed ID: 26005767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SER recommendations on treatment of refractory Behçet's syndrome.
    Moriano Morales C; Graña Gil J; Brito García N; Martín Varillas JL; Calvo Del Río V; Moya Alvarado P; Narváez García FJ; Espinosa G; Díaz Del Campo Fontecha P; Guerra Rodríguez M; Mateo Arranz J; López Gómez M; Francisco Hernández FM; Trujillo MM; Dos Santos Sobrín R; Martín Sánchez JI; Maese Manzano J; Suárez Cuba J
    Reumatol Clin (Engl Ed); 2024 Apr; 20(4):204-217. PubMed ID: 38614885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of interferon alpha-2a therapy in patients with Behcet's disease.
    Yalçindağ FN; Uzun A
    J Ocul Pharmacol Ther; 2012 Aug; 28(4):439-43. PubMed ID: 22455657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclosporin-A therapy in severe uveitis of Behçet's disease.
    Süllü Y; Oge I; Erkan D; Aritürk N; Mohajeri F
    Acta Ophthalmol Scand; 1998 Feb; 76(1):96-9. PubMed ID: 9541443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of current therapeutic strategies in Behçet's disease.
    Alexoudi I; Kapsimali V; Vaiopoulos A; Kanakis M; Vaiopoulos G
    Clin Rheumatol; 2011 Feb; 30(2):157-63. PubMed ID: 20842513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose intravenous steroid pulse therapy in ocular involvement of Behcet's disease: a pilot double-blind controlled study.
    Mohammadi M; Shahram F; Shams H; Akhlaghi M; Ashofteh F; Davatchi F
    Int J Rheum Dis; 2017 Sep; 20(9):1269-1276. PubMed ID: 28524639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential efficacy of human recombinant interferon-alpha2a on ocular and extraocular manifestations of Behçet disease: results of an open 4-center trial.
    Kötter I; Vonthein R; Zierhut M; Eckstein AK; Ness T; Günaydin I; Grimbacher B; Blaschke S; Peter HH; Stübiger N
    Semin Arthritis Rheum; 2004 Apr; 33(5):311-9. PubMed ID: 15079762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infliximab treatment for ocular and extraocular manifestations of Behçet's disease.
    Accorinti M; Pirraglia MP; Paroli MP; Priori R; Conti F; Pivetti-Pezzi P
    Jpn J Ophthalmol; 2007; 51(3):191-6. PubMed ID: 17554481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late response to anti-TNF-α therapy in refractory mucocutaneous lesions of Behçet's disease.
    Aikawa NE; Gonçalves C; Silva CA; Gonçalves C; Bonfá E; de Carvalho JF
    Rheumatol Int; 2011 Aug; 31(8):1097-9. PubMed ID: 20012049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuro-behçet's disease in South Korea: clinical characteristics and treatment response.
    Yoon DL; Kim YJ; Koo BS; Kim YG; Lee CK; Yoo B
    Int J Rheum Dis; 2014 May; 17(4):453-8. PubMed ID: 24506839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.